Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017317627> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2017317627 endingPage "559" @default.
- W2017317627 startingPage "547" @default.
- W2017317627 abstract "In this study we report the part clinical trials have played in the registration (licensing) of psychotropic drugs in Finland, Norway and Sweden. We studied the number and quality of clinical trials in the applications submitted by the drug industry to control authorities in the years 1965, 1970 and 1974/75, and the consideration of these applications by the control authorities. Applications for new single drugs contained many clinical trials, but most of them were uncontrolled, otherwise deficient or concerned only some of the indications applied for. Applications for new combination preparations as well as for synonym drugs rarely included controlled trials. The amount of clinical evidence increased with time, but this was largely because the numbers of combination and synonym drugs decreased. Comparisons with the applications for registration for other drugs showed that the applications for psychotropic drugs were not atypically poor. Different trials were often used in the applications for the same drug in Finland and Sweden, and not all trials notified to be carried out in Finland were included in the Finnish applications. The process of deciding whether or not a drug should be registered varied in the three countries as well as the decisions. Registration seemed to be easiest in Finland and strictest in Norway. In Finland and Sweden we related the quality of clinical trials to the decisions about registration. New drugs were sometimes registered for indications for which there were no good controlled trials. Thus, efficacy could not have been proved by the documentation included in the application. The following recommendations are made: re-evaluation of the efficacy of registered drugs should be carried out, and new registration criteria, an active registration policy, and different resource allocation could be considered." @default.
- W2017317627 created "2016-06-24" @default.
- W2017317627 creator A5006274501 @default.
- W2017317627 creator A5090681563 @default.
- W2017317627 date "1980-12-01" @default.
- W2017317627 modified "2023-10-16" @default.
- W2017317627 title "Psychotropic drug registration in thescandinavian countries: The role of clinical trials" @default.
- W2017317627 cites W1987944392 @default.
- W2017317627 cites W2089833278 @default.
- W2017317627 cites W2247350127 @default.
- W2017317627 doi "https://doi.org/10.1016/s0271-7123(80)80062-9" @default.
- W2017317627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7209629" @default.
- W2017317627 hasPublicationYear "1980" @default.
- W2017317627 type Work @default.
- W2017317627 sameAs 2017317627 @default.
- W2017317627 citedByCount "5" @default.
- W2017317627 crossrefType "journal-article" @default.
- W2017317627 hasAuthorship W2017317627A5006274501 @default.
- W2017317627 hasAuthorship W2017317627A5090681563 @default.
- W2017317627 hasConcept C111472728 @default.
- W2017317627 hasConcept C138885662 @default.
- W2017317627 hasConcept C142724271 @default.
- W2017317627 hasConcept C19527891 @default.
- W2017317627 hasConcept C199360897 @default.
- W2017317627 hasConcept C204787440 @default.
- W2017317627 hasConcept C2778653282 @default.
- W2017317627 hasConcept C2779530757 @default.
- W2017317627 hasConcept C2780035454 @default.
- W2017317627 hasConcept C2992672634 @default.
- W2017317627 hasConcept C41008148 @default.
- W2017317627 hasConcept C512399662 @default.
- W2017317627 hasConcept C535046627 @default.
- W2017317627 hasConcept C56666940 @default.
- W2017317627 hasConcept C71924100 @default.
- W2017317627 hasConcept C98274493 @default.
- W2017317627 hasConceptScore W2017317627C111472728 @default.
- W2017317627 hasConceptScore W2017317627C138885662 @default.
- W2017317627 hasConceptScore W2017317627C142724271 @default.
- W2017317627 hasConceptScore W2017317627C19527891 @default.
- W2017317627 hasConceptScore W2017317627C199360897 @default.
- W2017317627 hasConceptScore W2017317627C204787440 @default.
- W2017317627 hasConceptScore W2017317627C2778653282 @default.
- W2017317627 hasConceptScore W2017317627C2779530757 @default.
- W2017317627 hasConceptScore W2017317627C2780035454 @default.
- W2017317627 hasConceptScore W2017317627C2992672634 @default.
- W2017317627 hasConceptScore W2017317627C41008148 @default.
- W2017317627 hasConceptScore W2017317627C512399662 @default.
- W2017317627 hasConceptScore W2017317627C535046627 @default.
- W2017317627 hasConceptScore W2017317627C56666940 @default.
- W2017317627 hasConceptScore W2017317627C71924100 @default.
- W2017317627 hasConceptScore W2017317627C98274493 @default.
- W2017317627 hasIssue "6" @default.
- W2017317627 hasLocation W20173176271 @default.
- W2017317627 hasLocation W20173176272 @default.
- W2017317627 hasOpenAccess W2017317627 @default.
- W2017317627 hasPrimaryLocation W20173176271 @default.
- W2017317627 hasRelatedWork W198631773 @default.
- W2017317627 hasRelatedWork W2372770165 @default.
- W2017317627 hasRelatedWork W2416077810 @default.
- W2017317627 hasRelatedWork W2417673096 @default.
- W2017317627 hasRelatedWork W2488851463 @default.
- W2017317627 hasRelatedWork W2575073326 @default.
- W2017317627 hasRelatedWork W3190750342 @default.
- W2017317627 hasRelatedWork W4214484964 @default.
- W2017317627 hasRelatedWork W4250172493 @default.
- W2017317627 hasRelatedWork W2092514032 @default.
- W2017317627 hasVolume "14" @default.
- W2017317627 isParatext "false" @default.
- W2017317627 isRetracted "false" @default.
- W2017317627 magId "2017317627" @default.
- W2017317627 workType "article" @default.